Natalizumab Intravenous and Oxcarbazepine Extended-Release Tablets
Determining the interaction of Natalizumab Intravenous and Oxcarbazepine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: natalizumab
Brand name: Tysabri
Synonyms: Natalizumab
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Natalizumab Intravenous-Oxcarbazepine Oral Suspension
- Natalizumab Intravenous-Oxcarbazepine Suspension
- Natalizumab Intravenous-Oxcarbazepine Tablets
- Natalizumab Intravenous-Oxecta
- Natalizumab Intravenous-Oxilan
- Natalizumab Intravenous-Oxipor VHC
- Oxcarbazepine Extended-Release Tablets-Natalvirt 90 DHA
- Oxcarbazepine Extended-Release Tablets-Natalvirt CA
- Oxcarbazepine Extended-Release Tablets-Natazia
- Oxcarbazepine Extended-Release Tablets-Nateglinide
- Oxcarbazepine Extended-Release Tablets-Natelle Complete
- Oxcarbazepine Extended-Release Tablets-Natelle One